Dec 15, 2022 | Lung Cancer
2) I am Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare @HemOncFellows @Oncoalert and now we are covering @myESMO #ESMOImmuno22 updates/review on “Biomarker Targeted Therapies” in #LCSM! pic.twitter.com/sJb9PPWYFH— @onc_ce (@onc_ce) December 15,...
Oct 15, 2022 | Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #ADCs in development for #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹— @onc_ce (@onc_ce) October 18, 2022 3b) This content is intended for healthcare...
Sep 26, 2022 | Lung Cancer
2) Now we are covering @myESMO #ESMO22 updates on #HER2 mutant #LungCancer #LCSM. Our author is Antonio Passaro MD PhD (@APassaroMD) from @IEOufficiale, Milan in Italy 🇮🇹 pic.twitter.com/URaLLizjRH— @onc_ce (@onc_ce) September 27, 2022 3b) This content is...
Aug 15, 2022 | Lung Cancer
2) Now we are covering @IASLC #WCLC22 updates on #KRAS_mutated #LCSM! Our author is Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare @HemOncFellows @Oncoalert @KRASKickers pic.twitter.com/mDydm9D2vs— @onc_ce (@onc_ce) August 16, 2022 4a) #KRAS...
Jun 28, 2022 | Lung Cancer
2) Now we are covering @ASCO updates on #KRAS-mutated #cancers! Our author is #ASCO22 #FeaturedVoice Dr. Aakash Desai (@ADesaiMD) from @MayoHemOnc @MayoCancerCare and co-host @HemOncFellows. We will cover #KRAS in #LCSM, #GI malignancies & more. @Oncoalert...